Search clinical trials for: MEDI3250
Total 13 results
-
AstraZenecaCompletedHealthy Japanese Children Age 2 Years Through 6 YearsJapan
-
AstraZenecaCompletedHealthy Japanese Children Age 7 Years Through 18 YearsJapan
-
MedImmune LLCCompletedHealthy or Stable Underlying Chronic Medical ConditionUnited States
-
AstraZenecaCompletedAsthmaUnited States, Germany, United Kingdom, Argentina, Poland, South Africa, Hungary
-
MedImmune LLCCompletedPart I (SAD) - Healthy Participants | Part II (MAD) - Chronic Obstructive Pulmonary Disease | Part III (J-SD) - Healthy Japanese ParticipantsUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD) | Chronic BronchitisUnited States, Canada, Denmark, Spain, United Kingdom, Taiwan, New Zealand, Australia, Germany, Israel, South Africa, Czechia, Hungary, Poland, Netherlands
-
AstraZenecaCompletedAtopic DermatitisUnited States, Germany, Australia, Spain, United Kingdom, Poland
-
AstraZenecaCompleted
-
MedImmune LLCCompletedHealthy or Stable Chronic IllnessUnited States
-
AstraZenecaRecruitingViral Lung Infection and Acute Respiratory FailureUnited States, China, Australia, Czechia, Denmark, Hungary, Israel, Spain, United Kingdom, Canada, Germany, Italy, Argentina, Bulgaria, India, Turkey, Vietnam, Japan, France, Egypt, Malaysia, Taiwan, Thailand, Brazil, Greece, Belgium, Hong... and more
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMSI | dMMR Colorectal CancerFrance
-
AstraZenecaActive, not recruitingSolid TumorsUnited States, France
-
AstraZenecaCompletedDiabetic Kidney DiseaseUnited States, Chile, Korea, Republic of, Japan, Argentina, Canada, Peru